This document provides information about the MENA Pharma Excellence Congress taking place from March 28-31, 2016 in Dubai, UAE. The conference will discuss key issues facing the pharmaceutical industry through presentations and panel discussions. It will address topics like regulatory challenges, creating business models, improving sales and marketing, and enhancing industry-government collaboration. Experts from pharmaceutical companies and governments will speak. Attendees can choose between different registration packages that include access to workshops and presentations.
The recipe for excellence in pharmaceutical practice spotlight on menaMoustafa Magdy
This presentations provides an overview about the pharmaceutical business in Middle East Africa Region as well as practical guidance about business operation for excellence
Mena pharmaceuticals steps for successful model tphWesam Nehad
This is my presentation in Turkish and MENA pharmaceutical summit 3rd Nov.2015 in Istanbul
I tried to provide audience with practical steps to enter MENA pharmaceutical markets starting from market selection and prioritize them based on market size, growth, investment attractiveness, regulatory and setup challenges..etc. then the most common challenges and critical success factors to overcome most of those challenges ex. Entry models discussions, RA challenges, and reimbursement and market access challenges.
I end that with one interesting slide for XYZ product market access plan which took some discussions: when to start till the launch date, definitely market access shouldn't stop at the launch.. it is a continuous process
Hope you enjoy it and definitely I'm willing to share more information if required
Go to market strategies mena by wesam nehadWesam Nehad
MENA Pharmaceutical go to market strategies, what are the growth drivers, the challenges, which setup is perfect, what is the best market access planning
Key success factors to win in MENA pharmaceutical market, Market access planning, creating value, major challenges and changes in Pharmaceutical culture in MENA
The presentation discuss the size of the generic market in the Middle East and defining Jordan as a location suitable and attractive to put manufacturing plants.
The statistics also include health spending by country
The recipe for excellence in pharmaceutical practice spotlight on menaMoustafa Magdy
This presentations provides an overview about the pharmaceutical business in Middle East Africa Region as well as practical guidance about business operation for excellence
Mena pharmaceuticals steps for successful model tphWesam Nehad
This is my presentation in Turkish and MENA pharmaceutical summit 3rd Nov.2015 in Istanbul
I tried to provide audience with practical steps to enter MENA pharmaceutical markets starting from market selection and prioritize them based on market size, growth, investment attractiveness, regulatory and setup challenges..etc. then the most common challenges and critical success factors to overcome most of those challenges ex. Entry models discussions, RA challenges, and reimbursement and market access challenges.
I end that with one interesting slide for XYZ product market access plan which took some discussions: when to start till the launch date, definitely market access shouldn't stop at the launch.. it is a continuous process
Hope you enjoy it and definitely I'm willing to share more information if required
Go to market strategies mena by wesam nehadWesam Nehad
MENA Pharmaceutical go to market strategies, what are the growth drivers, the challenges, which setup is perfect, what is the best market access planning
Key success factors to win in MENA pharmaceutical market, Market access planning, creating value, major challenges and changes in Pharmaceutical culture in MENA
The presentation discuss the size of the generic market in the Middle East and defining Jordan as a location suitable and attractive to put manufacturing plants.
The statistics also include health spending by country
In Pharmaceutical business in Middle East, Are we really compliant to local regulations in our daily practice with HCPs and GO
Do we encourage and incentivize the compliant practice, regardless the impact on business?
Are we all responsible and accountable?
How can we build a compliant culture within our organizations, and what are this culture components?
How mature is the risk assessment and management in our cultures ?
Some questions I tried to answer in this short presentation I did during the 2nd annual pharma commercial and SEF summit in Dubai last month.
Please provide all your comments and guidance
Enjoy reading
13th Cairo marketing Club (Egyptian Pharma Market ) by Dr.Haytham MareiMahmoud Bahgat
13th Cairo marketing Club (Egyptian Pharma Market ) by Dr.Haytham Marei
*#Mahmoud_Bahgat*
*#Marketing_Club*
للاشتراك في نادي التسويق بالشرق الاوسط
*If you are a Marketer now*
To Join our whatsapp &Monthly Meeting in Middle East Cities
Send me ur data on Whatsap
00966569654916
*Fill ur data here as speaker or member*
https://lnkd.in/efkTE7T
Join now
*Marketing Club Facebook Page*
https://lnkd.in/gm4c4hD
*Marketing Club Facebook Group*
https://lnkd.in/gX-5au5
*Egyptian Pharmacists Society Facebook Page*
https://lnkd.in/fucnv_5
•••••••••••••••••••••••••••••
*#Mahmoud_Bahgat*
00966568654916
لخدمات التسويق والدعاية والاعلان
*#Legendary_ADLAND*
Complete Marketing Solutions
*www.LegendaryADLAND.com*
•••••••••••••••••••••••••••••
للحصول على اقامة او شركة في اوروبا
*#Legendary_Europe*
Europe Companies & Residency
*www.LegendaryEurope.info*
•••••••••••••••••••••••••••••
*Contact Bahgat*
M.Bahgat@TheLegendary.Info
East African Pharmaceutical Sector: Opportunities and ChallengesPharmaAfrica
Presentation by Nazeem Mohamed, Federation of East African Pharmaceutical Manufacturers made at the Euro-Africa Health Investment Conference, March 26 - 27, 2013, London, United Kingdom.
Target Market - A continent rich in prospects and enthusiasm, Africa could ha...PharmaAfrica
European Biopharmaceutical Review talks to PharmaAfrica about the vibrant and wide-ranging opportunities on offer for pharma companies looking to expand into new directions. July 2015 edition
The Growing Pharmaceutical Business in Latin America. By Fernando Ferrer. Mul...Fernando Ferrer, MBA
Presentation at the Meadowlands Chamber of Commerce. NJ, USA
Fernando Ferrer, MBA - October 30, 2013
The challenges of the Pharmaceutical business in Latin America
The global pharmaceutical retail market is forecasted to reach US$ 1.2 trillion by 2017.
The 33 Latin American countries when taking together possess certain regional common characteristics in their political, geographical, socio-economic, racial and cultural profile; but many peculiarities and differences that range from infrastructure to local regulations and market access, all of which must be understood in order to create and implement business strategies to capture the market of 600 million people.
Brazil, Mexico, Argentina and Venezuela rank already on the top 20 worldwide pharma markets. At a Compound Annual Growth Rate (CAGR) of 12% in 5 years, the sales forecast of the top 7 Latin American markets will reach close to US$ 110 billion, boosting the growth of other regional countries and life science markets.
During the presentation we will discuss on key factors to succeed when entering in these growing markets.
Greetings from Virtue Insight,
I am happy to invite you and your colleagues to be a sponsor/ delegate for our upcoming “9th Pharmacovigilance 2015” The conference will Be held on 2nd September 2015, Kohinoor Continental Hotel, Mumbai, India. Please find the detailed agenda for the same with this email.
FMD:- + 91 9171350244 or deepak@virtueinsight.co.in, deepakrajvirtueinsight@gmail.com
In Pharmaceutical business in Middle East, Are we really compliant to local regulations in our daily practice with HCPs and GO
Do we encourage and incentivize the compliant practice, regardless the impact on business?
Are we all responsible and accountable?
How can we build a compliant culture within our organizations, and what are this culture components?
How mature is the risk assessment and management in our cultures ?
Some questions I tried to answer in this short presentation I did during the 2nd annual pharma commercial and SEF summit in Dubai last month.
Please provide all your comments and guidance
Enjoy reading
13th Cairo marketing Club (Egyptian Pharma Market ) by Dr.Haytham MareiMahmoud Bahgat
13th Cairo marketing Club (Egyptian Pharma Market ) by Dr.Haytham Marei
*#Mahmoud_Bahgat*
*#Marketing_Club*
للاشتراك في نادي التسويق بالشرق الاوسط
*If you are a Marketer now*
To Join our whatsapp &Monthly Meeting in Middle East Cities
Send me ur data on Whatsap
00966569654916
*Fill ur data here as speaker or member*
https://lnkd.in/efkTE7T
Join now
*Marketing Club Facebook Page*
https://lnkd.in/gm4c4hD
*Marketing Club Facebook Group*
https://lnkd.in/gX-5au5
*Egyptian Pharmacists Society Facebook Page*
https://lnkd.in/fucnv_5
•••••••••••••••••••••••••••••
*#Mahmoud_Bahgat*
00966568654916
لخدمات التسويق والدعاية والاعلان
*#Legendary_ADLAND*
Complete Marketing Solutions
*www.LegendaryADLAND.com*
•••••••••••••••••••••••••••••
للحصول على اقامة او شركة في اوروبا
*#Legendary_Europe*
Europe Companies & Residency
*www.LegendaryEurope.info*
•••••••••••••••••••••••••••••
*Contact Bahgat*
M.Bahgat@TheLegendary.Info
East African Pharmaceutical Sector: Opportunities and ChallengesPharmaAfrica
Presentation by Nazeem Mohamed, Federation of East African Pharmaceutical Manufacturers made at the Euro-Africa Health Investment Conference, March 26 - 27, 2013, London, United Kingdom.
Target Market - A continent rich in prospects and enthusiasm, Africa could ha...PharmaAfrica
European Biopharmaceutical Review talks to PharmaAfrica about the vibrant and wide-ranging opportunities on offer for pharma companies looking to expand into new directions. July 2015 edition
The Growing Pharmaceutical Business in Latin America. By Fernando Ferrer. Mul...Fernando Ferrer, MBA
Presentation at the Meadowlands Chamber of Commerce. NJ, USA
Fernando Ferrer, MBA - October 30, 2013
The challenges of the Pharmaceutical business in Latin America
The global pharmaceutical retail market is forecasted to reach US$ 1.2 trillion by 2017.
The 33 Latin American countries when taking together possess certain regional common characteristics in their political, geographical, socio-economic, racial and cultural profile; but many peculiarities and differences that range from infrastructure to local regulations and market access, all of which must be understood in order to create and implement business strategies to capture the market of 600 million people.
Brazil, Mexico, Argentina and Venezuela rank already on the top 20 worldwide pharma markets. At a Compound Annual Growth Rate (CAGR) of 12% in 5 years, the sales forecast of the top 7 Latin American markets will reach close to US$ 110 billion, boosting the growth of other regional countries and life science markets.
During the presentation we will discuss on key factors to succeed when entering in these growing markets.
Greetings from Virtue Insight,
I am happy to invite you and your colleagues to be a sponsor/ delegate for our upcoming “9th Pharmacovigilance 2015” The conference will Be held on 2nd September 2015, Kohinoor Continental Hotel, Mumbai, India. Please find the detailed agenda for the same with this email.
FMD:- + 91 9171350244 or deepak@virtueinsight.co.in, deepakrajvirtueinsight@gmail.com
Indian Medical Advisors Summit 2014 HighlightsAnup Soans
INMAS - Indian Medical Advisors Summit is first of its kind initiative that has been
undertaken in India for the cause of Medical Affairs.
INMAS - Indian Medical Advisors Summit - 2014 - Watch Video on
www.youtube.com - https://www.youtube.com/watch?v=vCNVUlzyEpg
SMi Group presents the 23rd annual industry leading summit on Pharmaceutical Pricing & Market Access, 11 – 12 Oct 2017, London, UK.
Pharmaceutical Pricing & Market Access 2017 will tackle industry challenges head on by preparing attendees to develop a successful market access strategy for the ever changing pharmaceutical and payer landscape. Join us this autumn for insight into how manufactures plan to limit further price increase; a progressive outlook into the future of pharmaceutical pricing & reimbursement (P&R); stakeholder collaboration; meaningful patient engagement opportunities; and discuss what can be done for the industry to achieve efficient reimbursement and for patients to gain access to affordable medication.
Highlights will include an exclusive opening keynote from the FDA and interactive training on Real World Evidence (RWE). Featured Speakers include: Lundbeck, FDA, Shire, Sobi, Teva, Grifols, Allergan, Sanofi and more!
Greeting From Virtue Insight,
I am happy to invite you and your colleagues to be a sponsor/ delegate for our upcoming “9th Pharmacovigilance 2015” The conference will be held on 2nd September 2015, Kohinoor Continental Hotel, Mumbai, India.
KEY SPEAKERS:-
• V. Kalaiselvan, Principal Scientific Officer, Indian Pharmacopoeia Commission Ministry of Health and Family Welfare Govt. of India
• Arun Bhatt, President, ClinInvent Research
• Deepa Arora, Vice President - Pharmacovigilance & Global Head - Drug Safety & Risk Management, Lupin
• Bhaswat Chakraborty, Senior Vice President, Cadila
• Babita Kirodian, Head of Country Pharmacovigilance, Bristol Myers Squibb
• Nipom Deka, Regional Pharmacovigilance Manager, Asia, Africa & Middle East, Abbott
• Shashidhar Swamy, Head Pharmacovigilance, Wockhardt
• Mohammad Salim, Country Safety Lead, Pfizer
• Manish Verma, Director Medical Affairs, Sanofi
• Karthik Babu, Affiliate Pharmacovigilance Head, Sanofi
• Chirag Trivedi, Director & Head of Clinical Study Unit, Sanofi
• Priya Chatterjee, Director - Regulatory Affairs, Merck Serono
• Milind Antani, Partner In-Charge - Pharma LifeSciences, Nishith Desai Associate
• Anand Harugeri, Patient Safety and Regulatory Affairs Manager, Astrazeneca
• Deepti Sanghavi, Assistant Manager - Medical Writing, Tata Consultancy Services
• Sandeep Sewlikar, Manager – Clinical Affairs, Johnson and Johnson
• Girish Parhate, Head Regulatory Affairs, Bayer Pharmaceuticals
• Rajashri Survase Ojha, Founder and MD, Raaj GPRAC
• Vandana Jolad, Director, VIaTal Pharma
Plus Many More...
CONFERENCE BOOKING DETAILS:-
• Early Bird Discounted Price - Conference Delegate Pass (INR 6,000 + Tax (14%) per delegate) - Book and Pay before 20th July 2015 avail the early bird discounted price. You can simply email or call and book your conference delegate seats on TEL: +91 9940043915. Email – swetha@virtueinsight.co.in
• Standard Price after Early Bird Discounted Time – 1 or 2 Delegates (INR 7,000 + Tax (14%) per delegate) - You can simply email or call and book your conference delegate seats on TEL: +91 9940043915. Email – swetha@virtueinsight.co.in
• Group Discounts – 3 or 4 Delegates - (INR 6,500 + Tax (14%) per delegate)
• Group Discounts – 5 or more Delegates - (INR 5,000 + Tax (14%) per delegate)
• Conference Sponsor & Exhibition Stall - Should you wish to Sponsor, or purchase a Exhibition Stall (Booth) or a paid Speaker Slot, you can simply email your interest and queries to TEL: +91 44 65515695, +91 9940043915 or swetha@virtueinsight.co.in
In case you or any of your colleagues might be interested in participating in the same, please let me know and I will be happy to call you and help you with the registration.
Thank you for your time and consideration. I look forward to hearing from you
Thanks,
Swetha
DUPHAT is the premier Pharmaceutical and Technology event in the Middle East launched in 1995 by INDEX® Conferences and Exhibitions Org. Est., a member of INDEX Holding in collaboration with the government through the Dubai Health Authority with the aim to provide a high-quality conference and a wide-ranging exhibition.
DUPHAT is the premier Pharmaceutical and Technology event in the Middle East launched in 1995 by INDEX® Conferences and Exhibitions Org. Est., a member of INDEX Holding in collaboration with the government through the Dubai Health Authority with the aim to provide a high-quality conference and a wide-ranging exhibition.
Essential Elements of a Digital Strategy for the Launch of a New Product Anup Soans
Inside this Issue
1. Revive Pride in the Professions by K. Hariram
Less talk and more action is needed to attract, nurture and retain talent in pharma sales.
2. Ask an Expert: What are the Essential Elements of a Digital Strategy for the Launch of a New Product by Salil Kallianpur
3. Indian Pharma’s Image Problem by Noumaan Quereshi
Doctors are not pharma’s only customers and pharma needs to reach out to the broader community of stakeholders and win their trust.
4. Performance – the Unknown Creature by Hanno Wolfram
Performance KPIs need to be well-defined and unambiguous or else they lose their power to drive outcomes and affect change
5. Prof. Hattangadi’s Fantastic Journey in Pharma Brand Management interview with MedicinMan
Prof. Vivek Hattangadi’s incredible journey from cycle-cart salesman to to an author, professor and industry mentor
6. Dear MedicinMan
Answers to your queries on career and work-related issues answered by MedicinMan’s expert panel
7. Seen on Facebook
Interesting discussions on the social media
8. 9 Talent Management Challenges by K. Hariram
Brief from the 2014 OPPI Summit on “Attracting, Developing and Retaining Talent”
9. Tête-à-tête with Ameesh Masurekar at the Marketing Excellence Awards Ceremony 2014
Ameesh spoke to MedicinMan on the sidelines of the Awards and shared his thoughts on the awards and the future of the industry
The World Congress Summit - Leverage EHRs for Prescriber EngagementWorldCongress
This World Congress EHR Summit focuses on improving patient access by focusing on Health Information Technology and Health Information Management since the demand for Personal Health Management and Health Information Exchanges through ePrescribing and EHR portals has increased. Leverage Federal Quality Initiatives by supporting Meaningful Use through Electronic Health Records (EHRs)
Pharma Sales Force MENA 2010 will give you the opportunity to hear from global and regional experts, sharing useable techniques, strategies like Key Account Management (KAM) and Customer Relationship management (CRM) and technologies to considerably increase the success rate of your sales force.
For more information, visit www.pharmasalesforceme.com
With the current dynamic changes in the healthcare landscape in our region, there are numerous opportunities for pharmacists to work with the medical team on enhancing medication use, engage with patients, reduce safety risk and optimize patient outcomes by providing services such as medication management, preventive care, reconciliation, counselling and patient education.
The GCC Pharmacy Congress will help in integrating the medical team including pharmacists, nurses and physicians by discussing very important areas including but not limited to regulations, medication safety, medication reconciliation, supply chain management, antimicrobial stewardship, pharmacy benefits management, informatics, technologies and more.
Benefits of attending:
- Learn about innovations in implementing clinical pharmacy services in hospitals and ambulatory care
- Gain insights into the new technologies and innovations in pharmacy practice
- Review current issues and advances in medication safety
- Examine the pharmacists and nurses role of shared accountability in patient education and improving patient outcomes
- Optimise patient outcomes through safe, efficacious and cost-effective use of medications
- Obtain CME points by attending this congress
- Identify strategies for improving prescribing medicines in hospitals
- Drive the advancement of the technical, human and leadership competencies of pharmacists and pharmacy staff in complex and rapidly changing organisations
- Develop highly effective medication management strategies
- Attend a full day supply chain symposium to receive a broad set of perspectives and insights on some of the critical issues in Pharmaceutical supply chains
For more information or to register for the congress, visit the website www.gccpharmacongress.com
WELCOME TO THE HEALTHCARE INSURANCE FORUM!
Insurance privatisation is a new landscape for regional providers. It has extended a horizon of opportunities. Primarily, Insurance revolved around three models; integrating with the government, market led dictated by competition and a brown field transition from the ground up.
IIR Middle East's Healthcare Insurance Forum is an 8 year success story; a platform for interactive debate to identify opportunities this industry could benefit from. These discussions often lead to policy and framework implementation. Best practices are then shared across the region.
To raise the benchmark this year, research has helped guide us in engaging Healthcare's most important stakeholder – it's customer! We have therefore chosen – The Customer Experience – as the theme for the 9th Healthcare Insurance Forum, which will be held 26 – 29 January 2014 at the Dusit Thani Hotel, Dubai.
Led by a pre and post Forum workshop the two day conference will focus on:
ROI enhancing Cost Containment
Improving Provider Relations
Understating The Buyer's Perspective
By addressing wellness this Forum aims to nurture a society which prides it's health and revisit the core foundations Insurance was introduced for – Creating a Healthier population!
As an integral stakeholder in the Healthcare Insurance landscape, we look forward to your participation in pioneering this trend.
Prix Galien International 2024 Forum ProgramLevi Shapiro
June 20, 2024, Prix Galien International and Jerusalem Ethics Forum in ROME. Detailed agenda including panels:
- ADVANCES IN CARDIOLOGY: A NEW PARADIGM IS COMING
- WOMEN’S HEALTH: FERTILITY PRESERVATION
- WHAT’S NEW IN THE TREATMENT OF INFECTIOUS,
ONCOLOGICAL AND INFLAMMATORY SKIN DISEASES?
- ARTIFICIAL INTELLIGENCE AND ETHICS
- GENE THERAPY
- BEYOND BORDERS: GLOBAL INITIATIVES FOR DEMOCRATIZING LIFE SCIENCE TECHNOLOGIES AND PROMOTING ACCESS TO HEALTHCARE
- ETHICAL CHALLENGES IN LIFE SCIENCES
- Prix Galien International Awards Ceremony
Anti ulcer drugs and their Advance pharmacology ||
Anti-ulcer drugs are medications used to prevent and treat ulcers in the stomach and upper part of the small intestine (duodenal ulcers). These ulcers are often caused by an imbalance between stomach acid and the mucosal lining, which protects the stomach lining.
||Scope: Overview of various classes of anti-ulcer drugs, their mechanisms of action, indications, side effects, and clinical considerations.
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...VarunMahajani
Disruption of blood supply to lung alveoli due to blockage of one or more pulmonary blood vessels is called as Pulmonary thromboembolism. In this presentation we will discuss its causes, types and its management in depth.
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...kevinkariuki227
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdfAnujkumaranit
Artificial intelligence (AI) refers to the simulation of human intelligence processes by machines, especially computer systems. It encompasses tasks such as learning, reasoning, problem-solving, perception, and language understanding. AI technologies are revolutionizing various fields, from healthcare to finance, by enabling machines to perform tasks that typically require human intelligence.
micro teaching on communication m.sc nursing.pdfAnurag Sharma
Microteaching is a unique model of practice teaching. It is a viable instrument for the. desired change in the teaching behavior or the behavior potential which, in specified types of real. classroom situations, tends to facilitate the achievement of specified types of objectives.
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists Saeid Safari
Preoperative Management of Patients on GLP-1 Receptor Agonists like Ozempic and Semiglutide
ASA GUIDELINE
NYSORA Guideline
2 Case Reports of Gastric Ultrasound
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Oleg Kshivets
RESULTS: Overall life span (LS) was 2252.1±1742.5 days and cumulative 5-year survival (5YS) reached 73.2%, 10 years – 64.8%, 20 years – 42.5%. 513 LCP lived more than 5 years (LS=3124.6±1525.6 days), 148 LCP – more than 10 years (LS=5054.4±1504.1 days).199 LCP died because of LC (LS=562.7±374.5 days). 5YS of LCP after bi/lobectomies was significantly superior in comparison with LCP after pneumonectomies (78.1% vs.63.7%, P=0.00001 by log-rank test). AT significantly improved 5YS (66.3% vs. 34.8%) (P=0.00000 by log-rank test) only for LCP with N1-2. Cox modeling displayed that 5YS of LCP significantly depended on: phase transition (PT) early-invasive LC in terms of synergetics, PT N0—N12, cell ratio factors (ratio between cancer cells- CC and blood cells subpopulations), G1-3, histology, glucose, AT, blood cell circuit, prothrombin index, heparin tolerance, recalcification time (P=0.000-0.038). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and PT early-invasive LC (rank=1), PT N0—N12 (rank=2), thrombocytes/CC (3), erythrocytes/CC (4), eosinophils/CC (5), healthy cells/CC (6), lymphocytes/CC (7), segmented neutrophils/CC (8), stick neutrophils/CC (9), monocytes/CC (10); leucocytes/CC (11). Correct prediction of 5YS was 100% by neural networks computing (area under ROC curve=1.0; error=0.0).
CONCLUSIONS: 5YS of LCP after radical procedures significantly depended on: 1) PT early-invasive cancer; 2) PT N0--N12; 3) cell ratio factors; 4) blood cell circuit; 5) biochemical factors; 6) hemostasis system; 7) AT; 8) LC characteristics; 9) LC cell dynamics; 10) surgery type: lobectomy/pneumonectomy; 11) anthropometric data. Optimal diagnosis and treatment strategies for LC are: 1) screening and early detection of LC; 2) availability of experienced thoracic surgeons because of complexity of radical procedures; 3) aggressive en block surgery and adequate lymph node dissection for completeness; 4) precise prediction; 5) adjuvant chemoimmunoradiotherapy for LCP with unfavorable prognosis.
These simplified slides by Dr. Sidra Arshad present an overview of the non-respiratory functions of the respiratory tract.
Learning objectives:
1. Enlist the non-respiratory functions of the respiratory tract
2. Briefly explain how these functions are carried out
3. Discuss the significance of dead space
4. Differentiate between minute ventilation and alveolar ventilation
5. Describe the cough and sneeze reflexes
Study Resources:
1. Chapter 39, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 34, Ganong’s Review of Medical Physiology, 26th edition
3. Chapter 17, Human Physiology by Lauralee Sherwood, 9th edition
4. Non-respiratory functions of the lungs https://academic.oup.com/bjaed/article/13/3/98/278874
1. Strategic Partner: Media Partners:
Public Relations
Day by Day To the Top
Registerbefore
28
Februaryand
save
up
to
USD
300
Key Benefits of Attending:
An initiative by:
JOINING FORCES TO REACH EXCELLENCE IN PHARMACEUTICAL INDUSTRY
Pre-conference Workshops: 28-29 March 2016 | International Conference: 30-31 March 2016 | Dubai, UAE
Government Representation
• Hear top regional and international experts discuss the most pressing issues facing
the pharmaceutical industry
• Create partnerships with different stakeholders to build trust and redefine
strategies of growth
• Establish latest innovative solutions that enhance performance
• Improve sales and marketing tools that enable local and global success
• Participate in practical workshops designed to help you overcome the key
challenges facing the pharmaceutical industry
• Network, meet and build relationships with peers in the pharmaceutical
field
H.E. Amin Al Amiri
Assistant Undersecretary
for Public Health and Licensing
Ministry of Health, UAE
Dr. Hayel Obeidat
Director General
Jordanian Food and
Drug Administration JFDA
2. EXPERT SPEAKER FACULTY INCLUDE:
Ahmed Abo Al Fadl, Franchise Director GCC, Merck Serono
H.E. Amin Al Amiri, Assistant Undersecretary for Public Health and Licensing,
Ministry of Health, UAE
Dr. Ashraf Allam, VP ME, Mundipharm, Chairman, PhRMA
Dr. Fatima Al Breiki, Group Pharmaceutical Director, SEHA
Dr. Hayel Obeidat, Director General, Jordanian Food and Drug Administration
JFDA
Dr. Hosam Badr, Marketing Director, Julphar
Dr. Kamal El Dessouky, Therapeutic Area Lead, AFME, Pfizer
Dr. Karine Labaky, GM Global Pharma, Sanofi
Dr. Kasem Akhras, Head, MENA Market Access, Novartis
Dr. Khaled Mansour, Head of Market Access and External Affairs for EMEA
Emerging Markets, Janssen
Dr. Laura Nassar, Head of Compliance, ME, Roche
Dr. Mahmoud Ghaly, Regional GCC Manager, SPIMACO
Marwan Abdul Janahi, Executive Director, Dubai Science Park
Dr. Mohamed Galal, Head of ME, Consumer Care Division, Bayer
Dr. Mohamed Nasser, GM TMEA, Hospira
Dr. Nadia Younis, Director, Public Affairs and Communication Lead-Gulf and
Levant, Pfizer
Ossama Ibrahim, Area Sales Manager – General Medicine, North Gulf Region,
Merck Serono
Dr. Saad Fahmy, Compliance Director, ME, Sanofi
Dr. Wisam Haddadin, Head, EMEA Market Access, MSD
Dr. Yacoub Haddad, Government Affairs Director MEAP, Abbvie, Chairman,
PhRMAG
WITH A SPECIAL THANKS TO THE ADVISORY BOARD:
:
Dr. Emad Wagih, Senior Commercial Director-Gulf & Near East, Lundbeck
Dr. Kasem S Akhras, Head, MENA Market Access, Novartis
Dr. Nadia Younis, Director, Public Affairs and Communication Lead- Gulf & Levant,
Pfizer
Patrick Eckert, Region Head MENA (Oncology), Novartis Pharma services
Dr. Rami Rajab, Chairman, Medical Technology Association Middle East, Mecomed
Wael Soliman, Commercial Excellence Director-MENA and Area Head of
Operations, Genzyme
Dr. Wisam Haddadin, EMEA Head of Market Access, MSD
Dr. Yacoub Haddad, Director of Government Affairs MEAP, Abbvie and Chairman
of PhRMAG
Policy makers from the healthcare industry
Leaders from pharmaceutical companies including CEOs and Managing
Directors
The following functions at pharmaceutical companies: medical affairs,
regulatory, market access, commercial excellence, sales, marketing, CRM, etc.
“Many thanks. I learnt a lot throughout the
two-day congress. Different topics presented
by thought leaders.”
Eman Amin, Multichannel Marketing
Manager of Gulf and Levant, Pfizer
“The congress is a very good event, especially
for meeting decision makers within the
pharmaceutical industry and the key opinion
leaders within the market. It’s a very targeted
event to come to know the key players. The
leadership training was excellent.”
Amro Madi, Business Development Manager
– MENA Region, Elsevier Pharma Solutions
For more information or to register, contact us at +971 4 361 9616 info@mepharmaexcellence.com or visit www.mepharmaexcellence.com
CONFERENCE OVERVIEW
The MENA Pharma Excellence Congress is the premier platform for the
pharmaceutical industry and attracts senior local, regional and international leaders
from the pharmaceutical industry and government representatives to discuss key
issues facing the pharmaceutical industry through a number of interactive
presentations, panel discussions and on-stage interviews.
Delegates will have the opportunity to hear from leading experts from across the
region and the globe who will discuss the current regulatory environment in the
region, key challenges facing the pharmaceutical companies such as pricing,
reimbursement, market access, creating successful business models to drive growth
to the industry, improve access to medicine and improving sales and marketing
effectiveness by using the latest trends in technologies and creating effective
partnership to strengthen relation with the key stakeholders.
WHO SHOULD ATTEND
TESTIMONIALS
3. CONFERENCE DAY ONE: WEDNESDAY, 30 March 2016
11:40 Key Leaders Interactive Panel Discussion: Addressing market access
challenges and reviewing regulatory environment in the Middle East
Dr. Kasem Akhras, Head, MENA Market Access, Novartis
Dr. Wisam Haddadin, Head, EMEA Market Access, MSD
Dr. Khaled Mansour, AHead of Market Access and External Affairs for EMEA Emerging
Markets, Janssen
Dr. Mohamed Nasser, GM TMEA, Hospira
12:20 Lunch break
INTEGRATING BEST PRACTICES TO REACH PHARMA EXCELLENCE:
PUTTING COMPLIANCE CODES INTO ACTION
13:30 Key Leaders Interactive Panel Discussion: Creating successful business
models to adapt to the current situation in the market and aligned to
the international compliance code of conduct
Dr. Saad Fahmy, Compliance Director, ME, Sanofi
Dr. Ashraf Allam, VP ME ,Mundipharm, Chairman, PhRMA
Dr. Hosam Badr, Marketing Director, Julphar
14:10 Joint Presentation: Highlights on the Middle East Ethical Code of
Conduct
Dr. Saad Fahmy, Compliance Director, ME, Sanofi
Dr. Laura Nassar, Head of Compliance, ME, Roche
14:50 Networking break
15:20 Key Leaders Interactive Panel Discussion: Enhancing collaboration
between multinational and local Pharma companies in order to adopt
more compliant organisation systems
Dr. Laura Nassar, Head of Compliance, ME, Roche
Dr. Saad Fahmy, Compliance Director, ME, Sanofi
Dr. Hosam Badr, Marketing Director, Julphar
16:00 Closing remarks and end of day one
08.00 Registration, coffee and networking
08.50 Welcome from Maarefah Management
Dr. Doaa Said, Managing Director, Maarefah Management
PROMOTING INVESTMENTS IN PHARMACEUTICAL INDUSTRY
09:00 Official welcome and opening address from Ministry of Health
H.E. Amin Al Amiri, Assistant Undersecretary for Public Health Policy and Licensing,
Ministry of Health, UAE
09:40 Reviewing the JFDA role in facilitating investment and growth in the
pharmaceutical sector
Dr. Hayel Obeidat, Director, Jordanian Food and Drug Administration (JFDA)
10:20 Networking break
ENHANCING INDUSTRY-GOVERNMENT COLLABORATION IN THE
MENA REGION
11:00 Key Leaders Interactive Panel Discussion: Enhancing collaboration
between the governments and the pharmaceutical companies to
advance the pharmaceutical industry in the region
Dr. Hayel Obeidat, Director, Jordanian Food and Drug Administration (JFDA
Dr. Ashraf Allam, VP Middle East, Mundipharm, Chairman, PhRMA
Dr. Yacoub Haddad, Government affairs director Middle East Africa and Pakistan,
Abbvie, Chairman, PhRMAG
Dr. Mohamed Galal, Head of Middle East, Bayer
Marwan Abdul Janahi, Executive Director, Dubai Science Park
For more information or to register, contact us at +971 4 361 9616 info@mepharmaexcellence.com or visit www.mepharmaexcellence.com
“What I like about this congress is that the speakers were well-versed and experienced,
the congress was organised well and hosted in venue that boasts good standards. The
agenda was thoughtfully and carefully put together and the time allocation was spot on.
I also enjoyed the networking coffee breaks.”
Ahmed El Khamisi, Senior Consultant, IMS Health
TESTIMONIAL
4. CONFERENCE DAY TWO: THURSDAY, 30 March 2016
08:00 Registration, coffee and networking
08:30 Chairman’s welcome and opening remarks
ENHANCING VALUE OF INDUSTRY PARTNERSHIP WITH PROVIDERS
AND PATIENTS
09:00 The role of content marketing in strengthening relations with healthcare
professionals and patients
Dr. Hosam Badr, Marketing Director, Julphar
09:40 Market Access: Changing the perspective from product focus to patient
focus
Dr. Wisam Haddadin, Head, EMEA Market Access, MSD
10:20 Onstage Interview: Delivering value through public -private partnership
Dr. Karine Labaky, GM Global Pharma, Sanofi
11:00 Networking break
11:30 Leadership, talents and resources: The challenging mix
How companies can optimise their performance to provide best service for HCP’s by
allocating resources in: developing situational leadership to match the continuous
changing market requirements; empowerment for the talents and best resources
allocation
Ossama Ibrahim, Area Sales Manager – General Medicine, North Gulf Region, Merck
Serono
12:20 Key Leaders Interactive Panel Discussion: How to build a successful
relationship with healthcare providers
Dr. Fatima Al Breiki, Group Pharmaceutical Director, SEHA
Dr. Mohamed Nasser, GM TMEA, Hospira
Dr. Nadia Younis, Director, Public Affairs and Communication Lead-Gulf and Levant,
Pfizer
13:00 Lunch Break
UTILISING INNOVATIVE SOLUTIONS TO IMPROVE OPERATIONAL
PERFORMANCE
14:00 Pharmaceutical branding: Latest techniques and strategies
Ahmed Abol Fadl, Franchise Director GCC, Merck Serono
14:40 Marketing innovative approaches in modern pharmaceutical
environment
Dr. Kamal El Dessouky, Therapeutic Area Lead, AFME, Pfizer
15:20 Networking Break
16:10 Implications of Six Sigma in pharmaceutical industry
Dr. Mahmoud Ghaly, Regional GCC Manager, SPIMACO
16:50 Closing remarks and end of day two
MENA Pharma Excellence Congress
MENA Pharma Excellence
@PharmExcellence
Join our conversation on:
For more information or to register, contact us at +971 4 361 9616 info@mepharmaexcellence.com or visit www.mepharmaexcellence.com
5. WORKSHOPS: MONDAY, 28 & TUESDAY, 29 MARCH 2016
Pre-conference Workshop 1
Monday, 28 March 2016
09:00 – 13:30 Market Access Strategies to Boost Access to
Innovative Treatments
Pharmaceutical companies in the Middle East face growing challenges to secure
reimbursement for products. Governments apply international price referencing,
health insurance agencies increasingly limit reimbursement, and constrained
health budgets hamper market access. Attend this workshop to develop leading
insights on pharmaceutical pricing, integrated market access strategies and
applied pharmacoeconomics.
Workshop Overview
Essential Concepts of Pricing in Pharmaceutical Markets
• Determining the optimal price by therapeutic are.
• Access maximization versus profit maximization: finding the balance
• Evaluating the impact of international price referencing
Presenting Value Propositions in an Integrated Market
Access Strategy
• Pharmacological Characteristics and Clinical Attributes of the therapeutic
agent
• Individual and Societal Attributes associated with the use of the therapeutic
agent
• Economic Attributes (short-term and long-term) and the reimbursement of
new therapeutic agents
Applying Pharmacoeconomic methods to identify Economic
Value Propositions
• How to apply cost-effectiveness analysis to determine economic attributes of
the therapeutic agent
• Case Study: Economic modelling in early breast cancer
• Innovative market access strategies to boost access to innovative treatments
Workshop Leader:
Dr. João L. Carapinha, Ph.D, Chief Market Access Scientist,
Carapinha & Company
For more information or to register, contact us at +971 4 361 9616 info@mepharmaexcellence.com or visit www.mepharmaexcellence.com
Pre-conference Workshop 2
Tuesday, 29 March 2016
09:00 – 13:30 Digital Marketing
Workshop Overview
Introduction to Digital Marketing
• Overview, Benefits for Pharma industry
Effective multichannel marketing
• Pay Per Click Advertising ( SEM )
• Mobile Pay Per Click
• Digital Display Advertising
• Remarketing
• Search Engine Optimisation
• Micro Blogging
• Apps
• Digital PR
How to use social media in marketing
• Social Media - Youtube, Facebook, Instagram advertising, LinkedIn advertising
Digital Promotion
• Promotion of Events, seminars
• Getting Reviews on facebook and google
Digital access to physicians and patients
• Forums, Email Marketing
• Sms Marketing
• Whatsapp
• Newsletter Campaigns
Digitalising sales force activities
• Handling Inbound enquiry calls
• Clear Call process and model for closing
• Objection handling
Closed loop marketing
Using latest analytics for Pharma marketing and sales
• How to monitor the campaign results on Google Analytics
• Setup and goals Monitor audience, Traffic sources
• Measure Conversions Reporting
Workshop Leader:
Christian Farioli, Digital Marketing Director, Lecturer & Consultant,
Digital Marketing Institute Middle East
6. E-mail: info@mepharmaexcellence.com
Tel: +971 4 361 9616
Fax: +971 4 361 4375
Web: www.mepharmaexcellence.com
EMAIL THIS FORM TO info@mepharmaexcellence.com or fax +971 4 361 4375
4 WAYS TO REGISTER
Bronze Package:
Early Bird: Book and pay
by December 28, 2015
Early Bird 2: Book and pay
by February 28, 2016
Standard Price
Pharma Companies USD 999 USD 799
Solution Providers USD 2,099 USD 1,499
USD 899
USD 1,999
Bronze Package includes:
• 2-day Conference • Networking Coffee Breaks • Lunch • Post-congress Presentation Access
• Certificate of Attendance
Silver Package:
Early Bird: Book and pay
by December 28, 2015
Early Bird 2: Book and pay
by February 28, 2016
Standard Price
Pharma Companies USD 1,799 USD 1,599
Solution Providers USD 2,999 USD 2,499
USD 1,699
USD 2,799
Silver Package includes:
• 2-day Conference • Networking Coffee Breaks • 1-day Workshops • Lunch • Post-congress Presentation
Access • Certificate of Attendance
Gold Package:
Early Bird: Book and pay
by December 28, 2015
Early Bird 2: Book and pay
by February 28, 2016
Standard Price
Pharma Companies USD 2,199 USD 1,799
Solution Providers USD 3,299 USD 2,799
USD 1,999
USD 2,999
Gold Package includes:
• 2-day Conference • Networking Coffee Breaks • 2-day Workshops • Lunch • Post-congress Presentation
Access • Certificate of Attendance
CONFERENCE PACKAGES
By Wire Transfer
By Credit Card
Please debit my credit card: Visa Master Card
Card No:
Valid From: Expiry Date:
Card Holders Name:
Authorised Signature:
Registration received on:
Full payment received:
Internal use only:
PAYMENT METHOD
Please complete in BLOCK CAPITALS as information is used to produce delegate badges.
Please photocopy for additional delegates and/or delegate with different addresses
DELEGATE 1 Mr Mrs Ms Dr Other
Name:
Organisation:
Title:
Tel:
Fax:
Email:
Website Address:
DELEGATE DETAILS
VENUE: InterContinental Dubai Festival City
Address: Dubai Festival City, P.O. Box 45777, Dubai, UAE
Tel No.: +971 4 701 1111
Website: http://www.ihg.com/intercontinental/hotels/gb/en/dubai/dxbhb/hoteldetail
Hotel and travel costs are not included in the registration fee.
ROOM RESERVATION
Special / corporate rate for room accommodation is available at the hotel.
You may contact the hotel directly as per the details above quoting MENA Pharmaceutical
Excellence Congress.
Team discounts available on request.
Check for special group discount for registration of 3 or more. Call +971 4 361 9616 for more
information.
VENUE AND ACCOMMODATION
TEAM DISCOUNTS
Registration and Payment Policy
• All participants must register prior to congress admission.
• Pre-registered participants are advised to present a copy of their
registration/payment slip at the onsite registration desk.
• Payment is due at the time of registration and includes lunches,
refreshments, conference materials and certificate of attendance.
• Your registration will not be confirmed until payment is received in full.
• Cheque payment may only be made from UAE and in AED. Kindly contact
us at info@mepharmaexcellence.com to discuss.
• EFT / Direct Deposit to be effected as per bank details on the invoice.
• Payment should be made within 7 days of invoice date.
• Payment can also be done through credit card or Paypal.
Discounts
• All early bird discounts require payment at the time of registration and
before the early bird deadline in order to receive any discount.
• Discount offers cannot be combined with any other offer.
Cancellation Policy
• Registration cancellations must be notified in writing by email to the
Maarefah office in Dubai. Email: info@mepharmaexcellence.com
• Cancellations received 30 working days prior to the event will receive a
refund of the registration fees, less an administration charge of 100 USD
of the congress fee.
• Cancellations made after, as well as 'no shows', are not eligible for a
refund.
• Refunds will be processed 2 months after the event completion date.
Liability
• Maarefah reserves the right to amend any part of the congress programme
if necessary, at any time.
• Maarefah will not be held liable for damages of any nature sustained by
delegates or accompanying persons, or loss of, or damage to their personal
property as a result of attending the congress or its related events.
• While every consideration has been taken when presenting the
demographics of the attendees in the programme, Maarefah does not
guarantee the exact demographics of the congress attendees and cannot
be held responsible for the same.
TERMS AND CONDITIONS
Pre-Conference Workshops: 28-29 March 2016
International Conference: 30-31 March 2016 | Dubai, UAE
YES! Please register me for:
Bronze
Bronze package does not include
Pre-conference Workshops
Silver
Silver package includes 1-day Workshop
Workshop Day 1
Workshop Day 2
Gold
Gold package includes Workshop Day 1
and Workshop Day 2
For more information or to register, contact us at +971 4 361 9616 info@mepharmaexcellence.com or visit www.mepharmaexcellence.com
E-mail: info@mepharmaexcellence.com
Tel: +971 4 361 9616
Fax: +971 4 361 4375
Web: www.mepharmaexcellence.com
EMAIL THIS FORM TO info@mepharmaexcellence.com or fax +971 4 361 4375
4 WAYS TO REGISTER
Bronze Package:
Early Bird: Book and pay
by December 28, 2015
Early Bird 2: Book and pay
by February 28, 2016
Standard Price
Pharma Companies USD 799 USD 899
Solution Providers USD 1,499 USD 1,999
USD 999
USD 2,099
Bronze Package includes:
• 2-day Conference • Networking Coffee Breaks • Lunch • Post-congress Presentation Access
• Certificate of Attendance
Silver Package:
Early Bird: Book and pay
by December 28, 2015
Early Bird 2: Book and pay
by February 28, 2016
Standard Price
Pharma Companies USD 1,599 USD 1,699
Solution Providers USD 2,499 USD 2,799
USD 1,799
USD 2,999
Silver Package includes:
• 2-day Conference • Networking Coffee Breaks • 1-day Workshops • Lunch • Post-congress Presentation
Access • Certificate of Attendance
Gold Package:
Early Bird: Book and pay
by December 28, 2015
Early Bird 2: Book and pay
by February 28, 2016
Standard Price
Pharma Companies USD 1,799 USD 1,999
Solution Providers USD 2,799 USD 2,999
USD 2,199
USD 3,299
Gold Package includes:
• 2-day Conference • Networking Coffee Breaks • 2-day Workshops • Lunch • Post-congress Presentation
Access • Certificate of Attendance
CONFERENCE PACKAGES
By Wire Transfer
By Credit Card
Please debit my credit card: Visa Master Card
Card No:
Valid From: Expiry Date:
Card Holders Name:
Authorised Signature:
Registration received on:
Full payment received:
Internal use only:
PAYMENT METHOD
Please complete in BLOCK CAPITALS as information is used to produce delegate badges.
Please photocopy for additional delegates and/or delegate with different addresses
DELEGATE 1 Mr Mrs Ms Dr Other
Name:
Organisation:
Title:
Tel:
Fax:
Email:
Website Address:
DELEGATE DETAILS
VENUE: InterContinental Dubai Festival City
Address: Dubai Festival City, P.O. Box 45777, Dubai, UAE
Tel No.: +971 4 701 1111
Website: http://www.ihg.com/intercontinental/hotels/gb/en/dubai/dxbhb/hoteldetail
Hotel and travel costs are not included in the registration fee.
ROOM RESERVATION
Special / corporate rate for room accommodation is available at the hotel.
You may contact the hotel directly as per the details above quoting MENA Pharmaceutical
Excellence Congress.
Team discounts available on request.
Check for special group discount for registration of 3 or more. Call +971 4 361 9616 for more
information.
VENUE AND ACCOMMODATION
TEAM DISCOUNTS
Registration and Payment Policy
• All participants must register prior to congress admission.
• Pre-registered participants are advised to present a copy of their
registration/payment slip at the onsite registration desk.
• Payment is due at the time of registration and includes lunches,
refreshments, conference materials and certificate of attendance.
• Your registration will not be confirmed until payment is received in full.
• Cheque payment may only be made from UAE and in AED. Kindly contact
us at info@mepharmaexcellence.com to discuss.
• EFT / Direct Deposit to be effected as per bank details on the invoice.
• Payment should be made within 7 days of invoice date.
• Payment can also be done through credit card or Paypal.
Discounts
• All early bird discounts require payment at the time of registration and
before the early bird deadline in order to receive any discount.
• Discount offers cannot be combined with any other offer.
Cancellation Policy
• Registration cancellations must be notified in writing by email to the
Maarefah office in Dubai. Email: info@mepharmaexcellence.com
• Cancellations received 30 working days prior to the event will receive a
refund of the registration fees, less an administration charge of 100 USD
of the congress fee.
• Cancellations made after, as well as 'no shows', are not eligible for a
refund.
• Refunds will be processed 2 months after the event completion date.
Liability
• Maarefah reserves the right to amend any part of the congress programme
if necessary, at any time.
• Maarefah will not be held liable for damages of any nature sustained by
delegates or accompanying persons, or loss of, or damage to their personal
property as a result of attending the congress or its related events.
• While every consideration has been taken when presenting the
demographics of the attendees in the programme, Maarefah does not
guarantee the exact demographics of the congress attendees and cannot
be held responsible for the same.
TERMS AND CONDITIONS
Pre-Conference Workshops: 28-29 March 2016
International Conference: 30-31 March 2016 | Dubai, UAE
YES! Please register me for:
Bronze
Bronze package does not include
Pre-conference Workshops
Silver
Silver package includes 1-day Workshop
Workshop Day 1
Workshop Day 2
Gold
Gold package includes Workshop Day 1
and Workshop Day 2
For more information or to register, contact us at +971 4 361 9616 info@mepharmaexcellence.com or visit www.mepharmaexcellence.com
/ /